메뉴 건너뛰기




Volumn 120, Issue 3, 2012, Pages 132-138

Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation

Author keywords

Actovegin ; diabetes; neuropathy; neuroprotection; PARP; streptozotocin

Indexed keywords

ACETYLCYSTEINE; ACTOVEGIN; GLUCOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

EID: 84858151034     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1291248     Document Type: Article
Times cited : (30)

References (22)
  • 1
    • 33645099547 scopus 로고    scopus 로고
    • Interleukin-6 attenuates the development of experimental diabetes-related neuropathy
    • Andriambeloson E, Baillet C, Vitte P A et al. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology: 2006; 26 32 42
    • (2006) Neuropathology , vol.26 , pp. 32-42
    • Andriambeloson, E.1    Baillet, C.2    Vitte, P.A.3
  • 2
    • 47949102112 scopus 로고    scopus 로고
    • Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy
    • Bordet T, Buisson B, Michaud M et al. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. J Pharmacol Exp Ther: 2008; 326 623 632
    • (2008) J Pharmacol Exp Ther , vol.326 , pp. 623-632
    • Bordet, T.1    Buisson, B.2    Michaud, M.3
  • 4
    • 79953307499 scopus 로고    scopus 로고
    • Actovegin: A biological drug for more than 5 decades
    • Buchmayer F, Pleiner J, Elmlinger M et al. Actovegin: a biological drug for more than 5 decades. Wien Med Wochenschr: 2011; 161 3-4 80 88
    • (2011) Wien Med Wochenschr , vol.161 , Issue.34 , pp. 80-88
    • Buchmayer, F.1    Pleiner, J.2    Elmlinger, M.3
  • 5
    • 0035195970 scopus 로고    scopus 로고
    • Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
    • DOI 10.1007/s001250100001
    • Cameron N E, Eaton S E, Cotter M A et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia: 2001; 44 1973 1988 (Pubitemid 33124042)
    • (2001) Diabetologia , vol.44 , Issue.11 , pp. 1973-1988
    • Cameron, N.E.1    Eaton, S.E.M.2    Cotter, M.A.3    Tesfaye, S.4
  • 6
    • 0034741718 scopus 로고    scopus 로고
    • Effects of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes
    • DOI 10.1007/s001250100626
    • Cameron N E, Tuck Z, McCabe L et al. Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia: 2001; 44 1161 1169 (Pubitemid 32835509)
    • (2001) Diabetologia , vol.44 , Issue.9 , pp. 1161-1169
    • Cameron, N.E.1    Tuck, Z.2    McCabe, L.3    Cotter, M.A.4
  • 7
    • 33947310739 scopus 로고    scopus 로고
    • Diabetic painful neuropathy: Current and future treatment options
    • DOI 10.2165/00003495-200767040-00006
    • Chong M S, Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs: 2007; 67 569 585 (Pubitemid 46440313)
    • (2007) Drugs , vol.67 , Issue.4 , pp. 569-585
    • Chong, M.S.1    Hester, J.2
  • 8
    • 77954528687 scopus 로고    scopus 로고
    • New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}
    • Drel V R, Lupachyk S, Shevalye H et al. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}. Endocrinology: 2010; 151 2547 2555
    • (2010) Endocrinology , vol.151 , pp. 2547-2555
    • Drel, V.R.1    Lupachyk, S.2    Shevalye, H.3
  • 9
    • 64649093418 scopus 로고    scopus 로고
    • Intranasal insulin ameliorates experimental diabetic neuropathy
    • Francis G, Martinez J, Liu W et al. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes: 2009; 58 934 945
    • (2009) Diabetes , vol.58 , pp. 934-945
    • Francis, G.1    Martinez, J.2    Liu, W.3
  • 13
    • 36849058141 scopus 로고    scopus 로고
    • Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes
    • DOI 10.2337/db07-0740
    • Kellogg A P, Wiggin T D, Larkin D D et al. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes: 2007; 56 2997 3005 (Pubitemid 350223635)
    • (2007) Diabetes , vol.56 , Issue.12 , pp. 2997-3005
    • Kellogg, A.P.1    Wiggin, T.D.2    Larkin, D.D.3    Hayes, J.M.4    Stevens, M.J.5    Pop-Busui, R.6
  • 14
    • 0026080976 scopus 로고
    • Nature of enhanced mitochondrial oxidative metabolism by a calf blood extract
    • Kuninaka T, Senga Y, Senga H et al. Nature of enhanced mitochondrial oxidative metabolism by a calf blood extract. J Cell Physiol: 1991; 146 148 155 (Pubitemid 21910035)
    • (1991) Journal of Cellular Physiology , vol.146 , Issue.1 , pp. 148-155
    • Kuninaka, T.1    Senga, Y.2    Senga, H.3    Weiner, M.4
  • 16
    • 33644681565 scopus 로고    scopus 로고
    • Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: The relation is revisited
    • DOI 10.2337/diabetes.54.12.3435
    • Obrosova I G, Drel V R, Pacher P et al. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy. Diabetes: 2005; 54 3435 3441 (Pubitemid 43334333)
    • (2005) Diabetes , vol.54 , Issue.12 , pp. 3435-3441
    • Obrosova, I.G.1    Drel, V.R.2    Pacher, P.3    Ilnytska, O.4    Wang, Z.Q.5    Stevens, M.J.6    Yorek, M.A.7
  • 19
    • 78651101592 scopus 로고    scopus 로고
    • Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments
    • Tesfaye S, Boulton A J, Dyck P J et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care: 2010; 33 2285 2293
    • (2010) Diabetes Care , vol.33 , pp. 2285-2293
    • Tesfaye, S.1    Boulton, A.J.2    Dyck, P.J.3
  • 20
    • 33646437269 scopus 로고    scopus 로고
    • Remote neurotrophic support of epidermal nerve fibres in experimental diabetes
    • Toth C, Brussee V, Zochodne D W. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia: 2006; 49 1081 1088
    • (2006) Diabetologia , vol.49 , pp. 1081-1088
    • Toth, C.1    Brussee, V.2    Zochodne, D.W.3
  • 22
    • 68149106189 scopus 로고    scopus 로고
    • Treatment of Symptomatic Polyneuropathy with Actovegin in Type 2 Diabetic Patients
    • Ziegler D, Movsesyan L, Mankovsky B et al. Treatment of Symptomatic Polyneuropathy with Actovegin in Type 2 Diabetic Patients. Diabetes Care: 2009; 32 1479 1484
    • (2009) Diabetes Care , vol.32 , pp. 1479-1484
    • Ziegler, D.1    Movsesyan, L.2    Mankovsky, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.